» Articles » PMID: 34899053

The Effect of Race and Shear Stress on CRP-Induced Responses in Endothelial Cells

Overview
Publisher Wiley
Specialties Biochemistry
Pathology
Date 2021 Dec 13
PMID 34899053
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Background: C-reactive protein (CRP) is an independent biomarker of systemic inflammation and a predictor of future cardiovascular disease (CVD). More than just a pure bystander, CRP directly interacts with endothelial cells to decrease endothelial nitric oxide synthase (eNOS) expression and bioactivity, decrease nitric oxide (NO) production, and increase the release of vasoconstrictors and adhesion molecules. Race is significantly associated with CRP levels and CVD risks. With aerobic exercise, the vessel wall is exposed to chronic high laminar shear stress (HiLSS) that shifts the endothelium phenotype towards an anti-inflammatory, antioxidant, antiapoptotic, and antiproliferative environment. Thus, the purpose of this study was to assess the racial differences concerning the CRP-induced effects in endothelial cells and the potential role of HiLSS in mitigating these differences.

Methods: Human umbilical vein endothelial cells (HUVECs) from four African American (AA) and four Caucasian (CA) donors were cultured and incubated under the following conditions: (1) static control, (2) CRP (10 g/mL, 24 hours), (3) CRP receptor (FcRIIB) inhibitor followed by CRP stimulation, (4) HiLSS (20 dyne/cm, 24 hours), and (5) HiLSS followed by CRP stimulation.

Results: AA HUVECs had significantly higher FcRIIB receptor expression under both basal and CRP incubation conditions. Blocking FcRIIB receptor significantly attenuated the CRP-induced decrements in eNOS expression only in AA HUVECs. Finally, HiLSS significantly counteracted CRP-induced effects.

Conclusion: Understanding potential racial differences in endothelial function is important to improve CVD prevention. Our results shed light on FcRIIB receptor as a potential contributor to racial differences in endothelial function in AA.

Citing Articles

Construction and validation of a risk prediction model for postoperative lung infection in elderly patients with lung cancer.

Chen X, Wu L, Lan G, Li X, Wang X, Zhang P Medicine (Baltimore). 2024; 103(44):e40337.

PMID: 39495987 PMC: 11537623. DOI: 10.1097/MD.0000000000040337.


Race and sex differences in ROS production and SOD activity in HUVECs.

Mascone S, Kim K, Evans W, Prior S, Cook M, Ranadive S PLoS One. 2023; 18(10):e0292112.

PMID: 37792791 PMC: 10550108. DOI: 10.1371/journal.pone.0292112.


Plasma inflammatory biomarkers in cerebral small vessel disease: A review.

Wan S, Dandu C, Han G, Guo Y, Ding Y, Song H CNS Neurosci Ther. 2022; 29(2):498-515.

PMID: 36478511 PMC: 9873530. DOI: 10.1111/cns.14047.

References
1.
Feairheller D, Diaz K, Sturgeon K, Williamson S, Brown M . Racial Differences in the Time-Course Oxidative Stress Responses to Acute Exercise. J Exerc Physiol Online. 2011; 14(1):49-59. PMC: 3118095. View

2.
Dimmeler S, Haendeler J, Nehls M, Zeiher A . Suppression of apoptosis by nitric oxide via inhibition of interleukin-1beta-converting enzyme (ICE)-like and cysteine protease protein (CPP)-32-like proteases. J Exp Med. 1997; 185(4):601-7. PMC: 2196141. DOI: 10.1084/jem.185.4.601. View

3.
Janssens S, Flaherty D, Nong Z, Varenne O, van Pelt N, Haustermans C . Human endothelial nitric oxide synthase gene transfer inhibits vascular smooth muscle cell proliferation and neointima formation after balloon injury in rats. Circulation. 1998; 97(13):1274-81. DOI: 10.1161/01.cir.97.13.1274. View

4.
Michell B, Chen Zp , Tiganis T, Stapleton D, Katsis F, Power D . Coordinated control of endothelial nitric-oxide synthase phosphorylation by protein kinase C and the cAMP-dependent protein kinase. J Biol Chem. 2001; 276(21):17625-8. DOI: 10.1074/jbc.C100122200. View

5.
Ridker P . Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation. 2003; 107(3):363-9. DOI: 10.1161/01.cir.0000053730.47739.3c. View